{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:42:15Z","timestamp":1785825735569,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1245\/s10434-013-3224-y","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T18:11:19Z","timestamp":1377627079000},"page":"1474-1479","source":"Crossref","is-referenced-by-count":73,"title":["Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites"],"prefix":"10.1245","volume":"21","author":[{"given":"Reese W.","family":"Randle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina R.","family":"Swett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Swords","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Votanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,28]]},"reference":[{"key":"3224_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","volume":"63","author":"DZ Chu","year":"1989","unstructured":"Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63:364\u20137.","journal-title":"Cancer."},{"key":"3224_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000658-198606000-00009","volume":"203","author":"RN Garrison","year":"1986","unstructured":"Garrison RN, Kaelin LD, Galloway RH, Heuser LS. Malignant ascites. Clinical and experimental observations. Ann Surg. 1986;203:644\u201351.","journal-title":"Ann Surg."},{"key":"3224_CR3","unstructured":"Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess. 2008;12:iii\u2013ix, xi\u2013162."},{"key":"3224_CR4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jjco\/hym131","volume":"37","author":"SY Oh","year":"2007","unstructured":"Oh SY, Kwon HC, Lee S, et al. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites. Jpn J Clin Oncol. 2007;37:930\u20135.","journal-title":"Jpn J Clin Oncol."},{"key":"3224_CR5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1245\/s10434-009-0774-0","volume":"17","author":"A Husain","year":"2010","unstructured":"Husain A, Bezjak A, Easson A. Malignant ascites symptom cluster in patients referred for paracentesis. Ann Surg Oncol. 2010;17:461\u20139.","journal-title":"Ann Surg Oncol."},{"key":"3224_CR6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jamcollsurg.2004.01.035","volume":"198","author":"RA Adam","year":"2004","unstructured":"Adam RA, Adam YG. Malignant ascites: past, present, and future. J Am Coll Surg. 2004;198:999\u20131011.","journal-title":"J Am Coll Surg."},{"key":"3224_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","volume":"4","author":"SL Sangisetty","year":"2012","unstructured":"Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4:87\u201395.","journal-title":"World J Gastrointest Surg."},{"key":"3224_CR8","first-page":"2214","volume-title":"Cancer: principles and practice of oncology","author":"U Kammula","year":"2011","unstructured":"Kammula U. Malignant ascites. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 9th edition. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 2214\u20139.","edition":"9"},{"key":"3224_CR9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3748\/wjg.v16.i15.1901","volume":"16","author":"MC Ba","year":"2010","unstructured":"Ba MC, Cui SZ, Lin SQ, et al. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol. 2010;16:1901\u20137.","journal-title":"World J Gastroenterol."},{"key":"3224_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1072-7515(01)00980-2","volume":"193","author":"E Chang","year":"2001","unstructured":"Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg. 2001;193:225\u20139.","journal-title":"J Am Coll Surg."},{"key":"3224_CR11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000338070","volume":"6","author":"L Mestier de","year":"2012","unstructured":"de Mestier L, Volet J, Scaglia E, Msika S, Kianmanesh R, Bouche O. Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites? Case Rep Gastroenterol. 2012;6:166\u201370.","journal-title":"Case Rep Gastroenterol."},{"key":"3224_CR12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejso.2007.05.015","volume":"34","author":"E Facchiano","year":"2008","unstructured":"Facchiano E, Scaringi S, Kianmanesh R, et al. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol. 2008;34:154\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"3224_CR13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","volume":"32","author":"A Garofalo","year":"2006","unstructured":"Garofalo A, Valle M, Garcia J, Sugarbaker PH. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol. 2006;32:682\u20135.","journal-title":"Eur J Surg Oncol."},{"key":"3224_CR14","first-page":"237","volume":"30","author":"L Graziosi","year":"2009","unstructured":"Graziosi L, Bugiantella W, Cavazzoni E, Donini A. Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report. G Chir. 2009;30:237\u20139.","journal-title":"G Chir"},{"key":"3224_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jso.21321","volume":"100","author":"M Valle","year":"2009","unstructured":"Valle M, Van der Speeten K, Garofalo A. Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients. J Surg Oncol. 2009;100:331\u20134.","journal-title":"J Surg Oncol."},{"key":"3224_CR16","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1245\/s10434-011-1793-1","volume":"18","author":"AR Hill","year":"2011","unstructured":"Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH, Levine EA. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol. 2011;18:3673\u20139.","journal-title":"Ann Surg Oncol."},{"key":"3224_CR17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1245\/s10434-006-9304-5","volume":"14","author":"RP McQuellon","year":"2007","unstructured":"McQuellon RP, Danhauer SC, Russell GB, et al. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2007;14:1105\u201313.","journal-title":"Ann Surg Oncol."},{"key":"3224_CR18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1245\/s10434-012-2579-9","volume":"20","author":"N Tsilimparis","year":"2013","unstructured":"Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol. 2013;20:226\u201332.","journal-title":"Ann Surg Oncol."},{"key":"3224_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02987754","volume":"9","author":"FN Gilly","year":"1992","unstructured":"Gilly FN, Carry PY, Brachet A, et al. Treatment of malignant peritoneal effusion in digestive and ovarian cancer. Med Oncol Tumor Pharmacother. 1992;9:177\u201381.","journal-title":"Med Oncol Tumor Pharmacother."},{"key":"3224_CR20","first-page":"137","volume":"63","author":"BW Loggie","year":"1997","unstructured":"Loggie BW, Perini M, Fleming RA, Russell GB, Geisinger K. Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. Am Surg. 1997;63:137\u201343.","journal-title":"Am Surg."},{"key":"3224_CR21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF01675656","volume":"15","author":"Y Yonemura","year":"1991","unstructured":"Yonemura Y, Fujimura T, Fushida S, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg. 1991;15:530\u20135.","journal-title":"World J Surg."},{"key":"3224_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"key":"3224_CR23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","volume":"204","author":"EA Levine","year":"2007","unstructured":"Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204:943\u201353.","journal-title":"J Am Coll Surg."},{"key":"3224_CR24","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Fritz AG, Byrd DR, et al. AJCC cancer staging manual. 7th edition. New York: Springer; 2010.","edition":"7"},{"key":"3224_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"3224_CR26","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-3224-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3224-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:30:02Z","timestamp":1646436602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-3224-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,28]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["3224"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-3224-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,28]]}}}